Children at familial high risk of schizophrenia spectrum disorders (FHR-SZ) or bipolar disorder (FHR-BP) exhibit neurocognitive impairments. Large studies of neurocognition in young children at familial high risk at the same age are important to differentiate the pathophysiology and developmental trajectory of these 2 groups.
S chizophrenia is widely recognized as a neurodevelopmental disorder, [1] [2] [3] [4] with early neurocognitive deficits presenting well before the prodromal phase and first episode of psychosis. 5 The cognitive domains affected include intelligence, processing speed, verbal and visuospatial memory, attention, and executive functions before and after illness onset. [6] [7] [8] Bipolar disorder implicates many of the same neurocognitive deficits before and after illness onset, although to a lesser degree.
9-13
Neurocognitive deficits are core features of schizophrenia and bipolar disorder, 14 and thus research in the premorbid phase may characterize the developmental trajectories of the neurocognitive functions in their pathogenesis. Children of parents with schizophrenia or bipolar disorder are at increased familial (ie, genetic and environmental) risk of developing the same or other mental illnesses. 15 Consequently, a broadly recognized way to examine the pathogenesis of severe mental disorders is to study high-risk populations of first-degree relatives. 16 Previous familial high-risk studies 17 have demonstrated developmental abnormalities or neurocognitive deficits already in infancy in the children of parents with schizophrenia, including lower intelligence and verbal and visuospatial dysfunctions. These deficits are similar to, but less severe than, those seen in individuals diagnosed with schizophrenia. 18 The evidence concerning neurocognitive functioning in children of parents with bipolar disorder is scarce and contradictory. Neurocognitive deficits were not necessarily concurrent with significantly lower intelligence.
19
Neurocognitive functions have a high genetic load and a genetic overlap with illness proneness in individuals with schizophrenia and bipolar disorder. 24, 25 Thus, neurocognitive functions are considered endophenotypes or vulnerability markers for schizophrenia and bipolar disorder. 6, 26 Neurocognitive assessment of children at familial high risk of schizophrenia spectrum disorders (FHR-SZ) or bipolar disorder (FHR-BP) in early childhood provides a unique possibility for discriminating the neurocognitive profiles and differentiating the pathophysiology and developmental trajectory of these 2 familial high-risk groups with increased long-term risk of psychosis and other mental disorders. Ultimately, the identification of early neurocognitive deficits may enable the development of interventions to reduce the risk of transition.
27
The study objective was to characterize the neurocognitive functions of children with FHR-SZ or FHR-BP. We hypothesized that both groups would display impairments compared with a control group and that children with FHR-SZ would present more pronounced impairments than children with FHR-BP.
Methods

Participants
The Danish High Risk and Resilience Study VIA 7 (hereafter referred to as the VIA 7 study) is a population-based cohort study of 522 children aged 7 years who have at least 1 parent diag- . Children of parents with diagnoses of schizophrenia and bipolar disorder were assigned to the FHR-SZ group as per the ICD-10 hierarchy. The eMethods in the Supplement entails specifications of the ICD-8 and ICD-10 codes and information on differences between the participating and nonparticipating families. Approval from the Danish Data Protection Agency was obtained for this study. All procedures were performed according to the guidelines of the National Committee for Health Research Ethics, although formal approval was not deemed necessary by this authority owing to the observational nature of the study. All families received a thorough oral and written description of the study, and the parents or legal guardians of each child gave written informed consent.
The VIA 7 study design has been described in detail elsewhere. 28 . The reasons for the rather low proportion of families approached were that (1) during part of the data collection period, approximately 20% of the families were registered as protected from being approached for research purposes owing to legislation enacted in May 2011; and (2) for the entire period, some of the eligible children turned 8 years of age before the assessment capacity allowed for them to be enrolled. Dropout rates were less than 2%. The populationbased control group was matched with the children with FHR-SZ by age, sex, and municipality. A total of 10 controls were
Key Points
Questions Do 7-year-old children at familial high risk of schizophrenia spectrum disorders or bipolar disorder have neurocognitive impairments, and how do their neurocognitive profiles differ?
Findings This multisite population-based Danish cohort study of 514 children demonstrated significant neurocognitive impairments in those at familial high risk of schizophrenia, with the most pronounced deficits in processing speed and working memory. Children at familial high risk of bipolar disorder performed significantly better than children at familial high risk of schizophrenia, but did not differ significantly from controls.
Meaning Early identification of children at familial high risk of schizophrenia with neurocognitive impairments is warranted to monitor their developmental pathophysiology, prevent transition to psychosis, and inform early intervention programs.
retrieved for each child in the FHR-SZ group and the FHR-BP group; the original intent was to only select controls matched to children in the FHR-SZ group, but 38 FHR-BP-matched controls were included among the control group. All the participating children had Danish as their first language.
Procedures
The study assessors were trained psychologists (N.H., C.C., M.G., A.N.G., and D.L.G.), physicians (A.T., D.E., K.S.S., and B.K.B.), and nurses (A.S.) and were instructed, supervised, and certified by a specialist in child neuropsychology (J.R.M.J.). Most of the assessments were conducted at the research sites in Copenhagen and Aarhus, Denmark. A small number of assessments were performed in the homes of the participating families if the home allowed for equal conditions of the examination as in the research sites (ie, a quiet room, a suitable work desk, and no distractions). The child assessors were blinded to familial risk status.
Measures
We used the Children's Global Assessment Scale (CGAS) 31 to assess the current level of functioning and the Child Behavior Checklist (CBCL) School-Age Version (completed by the primary caregiver) to assess problem behavior. 32 The neuropsychological test battery (eTable 1 in the Supplement) was designed to map the neurocognitive functions affected in individuals with schizophrenia 33 or bipolar disorder 9,34 using well-established and validated tests. One key variable from each subtest was selected a priori (eTable 1 in the Supplement). The neurocognitive test performances were scored by trained psychology students who were blinded to the risk status of the children and supervised by a specialist in clinical child psychology (N.H.). A sample of the test performances of at least 40 children on the 17 test scores that were not computerized was rescored by the specialist in child psychology or a second trained psychology student who was blinded to the original scoring and the familial risk status. If the intraclass correlation coefficient was greater than 0.90, the initial scoring was accepted. Intraclass correlation coefficients were greater than 0.90 on all test scores.
Statistical Analysis
We compared demographic and clinical characteristics of the 3 study groups using univariate analysis of variance for continuous data and the χ 2 test for categorical data. Log transformation was used to approximate a normal distribution when appropriate (CBCL Total Score Number-Letter Switching) were applied so that all test scores approximated a normal distribution. All 23 test scores were standardized into z scores using the means and SDs of the control group as reference. The z scores were constructed so that a negative score always denoted a poorer performance. To reduce the risk of type I errors, we compared the 3 study groups on their performance on the 23 neurocognitive functions using multivariate analysis of variance (MANOVA). Significance for the mean comparisons was corrected using the Scheffé method and set at P < .05. Estimates of effect size were calculated with Cohen d. A multivariate analysis of covariance (MANCOVA) was conducted to control for potential effects of sex and age. In case of a significant result, separate univariate analysis of covariance (ANCOVA) was conducted with sex or age as the covariate. An intelligence composite score was created by restandardizing the mean z scores derived from the Reynolds Intellectual Screening Test, included in the Reynolds Intellectual Assessment Scales battery. 35 To assess the potential effects of intelligence on the observed between-group differences of the other neurocognitive z scores, we repeated the MANCOVA with the intelligence composite score as covariate. In case of a significant result, a series of ANCOVAs was conducted with intelligence as covariate. Potential associations between neurocognition and problem behavior were assessed by explorative bivariate correlation analyses between all 23 neurocognitive functions and the CBCL Total Score.
To reduce the number of variables, we conducted a principal component analysis of the 23 neurocognitive z scores using oblimin rotation with Kaiser normalization. We then compared the factor structure by study group by means of confirmatory factor analysis. 36 A minimum factor loading of 0.32 was used as a criterion for interpretation, 36 and in cases of cross loadings, the highest loading would determine to which factor a given observed measure would belong. Factor scores were restandardized into z scores using the means and SDs of the control group as reference. The factor z scores of the 3 study groups were compared using MANOVA to reduce the risk of type I errors. Scheffé post hoc analyses were used to compare mean differences across the 3 groups and the 4 neurocognitive factors. Effect size estimates were calculated using Cohen d. MANCOVA was conducted to control for potential effects of sex and age. In case of a significant result, a series of ANCOVAs was conducted with sex or age as the covariate. Data were analyzed using SPSS Statistics software (version 22; IBM Corp).
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Results
Demographic and Clinical Characteristics
In this multisite population-based cohort study, the study population of 514 children (238 were intermediate between scores in the other study groups and differed significantly from the control group on both scores (P = .009 and P = .02, respectively) and the FHR-SZ group on the CGAS score (P = .001).
Neurocognitive Functions
MANOVA showed a statistically significant effect of group on all 23 functions (F =1. 93;P < .001; Wilks λ = 0.84). The results of the pairwise comparisons (Table 2 ) revealed that the FHR-SZ group had a significantly poorer performance compared with controls on 14 of the 23 neurocognitive functions and compared with the FHR-BP group on 8 of the 23 neurocognitive functions with small to medium effect sizes. Results remained significant after adjusting for age and sex. Because the MANCOVA revealed a significant effect of sex, ANCOVAs controlling for sex were conducted on all 23 neurocognitive scores except for Guess What owing to lack of homogeneity of regression between the FHR-SZ and control groups. ANCOVAs controlling for sex did not change the significant between-group effect. Children with FHR-BP and controls did not differ significantly on any of the 23 neurocognitive functions. Owing to multicollinearity of the intelligence composite score and its subtest Guess What and Odd-Item Out scores, we conducted univariate analyses in the pairwise comparisons of the intelligence composite score. The intelligence composite score revealed a significant difference between the FHR-SZ and control groups (mean [SD] z score, −0.29 [1.20] vs 0 [1.00]) ( Table 2 ) that remained significant after adjusting for age and sex. Despite a significant effect of intelligence on all other 21 functions, the effect of group remained significant in all comparisons when controlling for intelligence. Owing to the fact that we have a considerably larger control group than the number of children used for this specific age range in the 
Neurocognitive Domains
After conducting principal component analysis, the following observed 4 neurocognitive factors were identified: (1) processing speed and working memory, (2) verbal functions, (3) executive and visuospatial functions, and (4) declarative memory and attention ( Table 3 ) (factor selection is explained in eMethods in the Supplement). Confirmatory factor analysis supported the 4-factor structure of neurocognitive functioning (factor invariance) across the 3 groups. MANOVA showed a statistically significant effect of group on the 4 factors (F = 3.76; P < .001; Wilks λ = 0.94). The results of the pairwise comparisons revealed that the FHR-SZ group was significantly impaired compared with the control group on processing speed and working memory (Cohen d = 0.50; P < .001), executive and visuospatial functions (Cohen d = 0.28; P = .03), and declarative memory and attention (Cohen d = 0.29; P = .02) ( Table 2) . Children with FHR-SZ also had a significantly poorer performance than children with FHR-BP on the same 3 factors significant after adjusting for age and sex. Again, MANCOVA revealed a significant effect of sex on the 4 neurocognitive factors, but after controlling for sex with a series of ANCOVAs, the results remained significant in all comparisons. We found no statistically significant differences between the FHR-BP and control groups on the 4 neurocognitive factors. Figure 1 and Figure 2 display the unadjusted neurocognitive profiles of the 3 study groups across all functions and domains.
Discussion
In this large, population-based cohort study with comprehensive neurocognitive assessments of familial high-risk offspring, we demonstrated widespread neurocognitive impairments in 7-year-old children with FHR-SZ in the domains of processing speed and working memory, executive and visuospatial functions, and declarative memory and attention. Children with FHR-BD did not show neurocognitive impairments at this young age. Children with FHR-SZ also had a significantly poorer performance than children with FHR-BP in the same domains. These findings suggest distinct neurodevelopmental pathophysiology and trajectory of these familial high-risk groups. Our findings of widespread neurocognitive impairments in children with FHR-SZ are consistent with findings of previous high-risk studies of first-degree relatives. 38 However, previous high-risk studies were small, including a wide age range, which introduces cognitive heterogeneity, or included adult relatives, which implicates attrition bias. A broad age range obscures the effects of cognitive maturation in the event of a neurocognitive developmental lag. Children developing schizophrenia in adulthood display developmental lags between the ages of 7 to 13 years in some neurocognitive functions. 39 Although speculative, the currently observed neurocognitive impairments may also reflect a developmental lag suggesting worse deficits with increasing age. Also, the larger effect sizes (predominantly in the medium range) reported in most of the studies on neurocognition in children with FHR-SZ (compared with the small to medium effect sizes in our study) may be explained by higher mean ages. 17 Thus, comparable small to medium effect sizes were observed in another study of 7-year-old children of parents with schizophrenia. 40 Our observation of widespread neurocognitive dysfunctions in children with FHR-SZ supports the hypothesis that schizophrenia is a disorder with substantial neurodevelopmental deficits, even in individuals with a mere vulnerability for the disorder. 46 We found no evidence of shared neurocognitive impairments between familial high risk of schizophrenia and bipolar disorder. Our findings suggest unimpaired early neurocognitive maturation in children with FHR-BP, although neurocognitive dysfunctions are reported to emerge later. 19, 21 In alignment with the model of Craddock and Owen, 46 our findings suggest more pronounced neurodevelopmental pathologic findings in children with FHR-SZ compared with 
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Neurocognitive Functions in Children at Familial High Risk of Schizophrenia or Bipolar Disorder differences. 39 In addition, they may identify neurocognitive predictors of conversion to psychosis and clarify which neurocognitive dysfunctions emerge in bipolar offspring and when.
Strengths and Limitations
Our study is, to our knowledge, the largest and most comprehensive familial high-risk study of neurocognition to date, including offspring with FHR-SZ and FHR-BP. All children were examined at the same age, which is unique within this field. The detailed assessment battery consisted of validated tests, and scoring was reliable. Register-based recruitment ensured an epidemiologically identified population with no referral bias. Finally, the dropout rate was low. Representativity analyses revealed that participating parents were slightly older than nonparticipating parents and that a higher proportion of participating families lived in densely populated areas in all 3 groups. We prioritized visuospatial memory, and a visuospatial construction score was not included. Finally, inclusion of children at familial high risk from an even younger age would have ensured the capturing of neurocognitive development from early childhood and onwards.
Conclusions
Neurocognitive impairments are widespread in 7-year-old children with FHR-SZ, supporting the notion of neurocognition as an endophenotype for schizophrenia and a target for intervention. Children with FHR-BP do not display neurocognitive deficits at this age, suggesting a less pronounced neurodevelopmental component. Early detection of children with FHR-SZ and cognitive impairments is warranted to (1) investigate associations of neurocognition with functional outcome and transition to psychosis, (2) add to the knowledge of their developmental pathophysiology, and (3) inform early intervention programs. 
Differences between participating and non-participating families
The sample was drawn from the national population of children who were seven years old in the study period and who had parents with schizophrenia or bipolar disorder together with matched control children (Figure 1 ). The mothers of the participating children were slightly but non-significantly older (0.4 years) compared to the mothers of the nonparticipating children. The fathers of the participating children were slightly and significantly older (0.5 years, P = .045) compared to the fathers of non-participating children with an age difference of 0.1 years (P = .92) in the FHR-SZ group, 1.8 years (P = .01) in the FHR-BP group, and 0.8 years (P = .04) in the control group. A significantly higher proportion of the participating families lived in densely populated areas (46.6% among participating versus 29.3% among nonparticipating families, P < .001). This pattern was exactly the same in the three study groups. Logistic problems most likely explained why fewer families from rural areas chose to take part.
II. Principal Component Analysis
To reduce the number of variables principal component analysis was conducted on the 23 neurocognitive z-scores. Factors with an eigenvalue >1 and scree plots were examined to identify the appropriate number of factors. Factorial invariance was confirmed separately in the three groups. Oblimin rotation with Kaiser normalization was applied. Bartlett's test of sphericity (p<0.0001) was significant and the relatively high Kaiser-Meyer-Olkin measure of sampling adequacy (KMO=0.9) supported factor analysis as a valid method for structure detection. Four factors were identified and considered conceptually interpretable in terms of neurocognitive domains. The four factors cumulatively explained 47% of the total variance. Factor scores were constructed as the sum of the factor coefficients (loadings) times the standardized neurocognitive test scores. 
